Emergent BioSolutions awarded $704M BARDA contract for Ebola treatment

Emergent BioSolutions Inc. was awarded a 10-year contract by BARDA valued at up to $704 million for advanced development, manufacturing scale-up, and procurement of Ebanga treatment for Ebola virus disease.

“Emergent BioSolutions Inc. announced today that it was awarded a 10-year contract by the Biomedical Advanced Research and Development Authority (BARDA) ... valued at up to a maximum of $704 million.”investors.emergentbiosolutions.com

• 1 source
• investors.emergentbiosolutions.comEmergent Biosolutions Inc. - Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for EbolaJul 31, 2023

Summarized from public sources; check the original articles before acting on it.